Clinical Trials
- Brain, Spinal Cord & Nervous System
Network Integrity in Neurodegenerative Disease
- Ages40 years - 90 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Meditation and Synaptic Density
- Ages28 years - 70 years
- GenderBoth